InvestorsHub Logo
Followers 16
Posts 4650
Boards Moderated 0
Alias Born 08/11/2015

Re: None

Friday, 06/16/2017 10:16:00 AM

Friday, June 16, 2017 10:16:00 AM

Post# of 18220
I mentioned this earlier in the week, but I'm going to say it again so I can put a sticky on it:

Three new board of directors were listed on the most recent 8-k:

Rufus (Rudy) Williams - Chief Operating Advisor
Dr. John H. Abeles - Senior Executive Advisor
Dr. Vincent Ahonkhai - Senior Regulatory Advisor

You can look up all of them, but the most important (in my opinion) of the three is Dr. Vincent Ahonkhai.

As some people on this message board have heard rumors (Noreen mentioned it during the January conference call), the GATES FOUNDATION will be helping Immune Therapeutics by funding initial purchase orders. This has not been confirmed in any publications and has not been documented anywhere, so it is hearsay.

However! Dr. Vincent Ahonkhai is IMUN's new Senior Regulatory Advisor. This is really amazing news, because he is also the Senior Regulatory Advisor for the BILL AND MELINDA GATES FOUNDATION! This tells me that the rumors are likely the truth. And this is huge!

https://www.researchgate.net/profile/Vincent_Ahonkhai

http://www.zoominfo.com/p/Vincent-Ahonkhai/2428292